Small Cap Stock Indaptus Therapeutics Inc (INDP) Is A Buy – Analysts
Indaptus Therapeutics Inc (NASDAQ:INDP) has a beta value of 1.56 and has seen 364.44 million shares traded in the last trading session. The company, currently
Indaptus Therapeutics Inc (NASDAQ:INDP) has a beta value of 1.56 and has seen 364.44 million shares traded in the last trading session. The company, currently
During the last session, Indaptus Therapeutics Inc (NASDAQ:INDP)’s traded shares were 93513.0, with the beta value of the company hitting 1.55. At the end of
In the latest trading session,, 3.72 million Indaptus Therapeutics Inc (NASDAQ:INDP) shares changed hands as the company’s beta touched 1.56. With the company’s most recent
During the recent session, Indaptus Therapeutics Inc (NASDAQ:INDP)’s traded shares were 9.02 million, with the beta value of the company hitting 1.55. At the last
© 2024, Powered by Smart TechOne